Structure Therapeutics

Drug Discovery · Cardiometabolic Therapeutics
3Open roles2 posted in 30 days
$210kMedian advertised pay
Lately:8 news stories in 90 daysFollow changes →

Facts

as of Nov 16, 2026

Structure Therapeutics is a clinical-stage biopharmaceutical company using structure-based and computational drug discovery to design oral small molecule medicines. Its platform targets diseases currently treated with biologic and peptide drugs, and it hires GCP quality assurance leaders, data scientists and AI security engineers. The company is headquartered in South San Francisco, California, United States.

It is hiring: 3 open roles, 2 of them posted in the last 30 days.

Headquarters
South San Francisco, United States
Open roles
3Alion job postings
Website
structuretx.com

As of Nov 16, 2026, Alion lists 3 open roles at Structure Therapeutics. Structure Therapeutics is headquartered in South San Francisco, United States.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Hiring at full speed: most open roles are fresh.

Leadership is the largest family, 50 of open roles.

2Posted in 30 days67% of open roles are fresh
67%Remote roles2 of 3
1Hiring offices
Can they hire you from United States?by your location
Likely
2 open roles are in your country: you apply locally, no move needed.
United States2On site
Remote, from elsewhere2Rare
No posting offers visa sponsorship. Remote roles: 2.
Alion signals0-100
Demand28
Pay25
Your chance36
How badly they need people, whether they pay, how realistic getting in is.
Where the openings areshare of open roles · trend
Leadership50▲
Data Science25▲
Security25▲
Newest roles
Director, Global GCP QA
$185k – $250k per year · Remote (likely United States) · Full-Time · 10+ years exp
Associate Director, Global GCP QA
$165k – $210k per year · Remote (likely United States) · Full-Time · 8+ years exp
AI Security Engineer
$147k – $185k per year · In office · Full-Time · South San Francisco
Benefits named in postingsshare of open roles
Vision insurance3100%
Equity267%
Unlimited PTO267%
401k plan267%
Contract type
Full-Time 3
Visa sponsorship: none statedRelocation: none stated
Source: the company's careers site, read by Alion several times a day; market medians from all open roles of the same family

Pay

What its postings pay, by level.

$210kMedian
$185k – $250kTypical rangeUSD a year
$250kHighest paying roleDirector, Global GCP QA
Source: the pay stated in the company's postings, normalised to USD a year

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
South San Francisco United StatesHeadquarters0
Source: office addresses in postings and company registers

Technologies named in job postings at Structure Therapeutics over the last 12 months, by layer, with the share of postings for each.

24Technologies in use
4Postings analysed
69/100Stack modernity
LanguagesPythonBashR
Frameworks & librariesPyTorchTensorFlowMatplotlibPlotly
Sign in to see how your skills match this stackSign In
Full Structure Therapeutics tech stack24 technologies · by team · pay by technology · changes · similar stacks
Source: the technologies named in the company's postings and on its site

Newsroom

Nov 122026
News · YahooFinance
Retrospective analysis at ObesityWeek will explore how AI-based modeling can provide context for longer-term obesity study resultsSAN FRANCISCO, CA / ACCESS Newswire / November 1…
Nov 122026
News · FinanzNachrichten.de
Retrospective analysis at ObesityWeek will explore how AI-based modeling can provide context for longer-term obesity study results SAN FRANCISCO, CA / ACCESS Newswire / November…
Nov 112026
Press release · The Globe and Mail
Detailed price information for Structure Therapeutics Inc (GPCR-Q) from The Globe and Mail including charting and trades.
Nov 102026
News · YahooFinance
Phase 3 ACCOMPLISH-1 and ACCOMPLISH-2 registrational clinical trials of aleniglipron (oral small molecule GLP-1 receptor agonist) enrolling; topline data expected in 2H 2028 Addi…
Sources: the outlets named on each headline, each story once